Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Bevacizumab+Rituximab

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roche blasts 'act of counterfeiting' for cancer drug in Pakistan
    Roche blasts 'act of counterfeiting' for cancer drug in Pakistan

    26 Sep 2023

    // Fraiser Kansteiner FIERCE PHARMA

    https://www.fiercepharma.com/pharma/roches-avastin-recalled-pakistan-after-patients-using-counterfeit-version-label-lost-their

    Fraiser Kansteiner FIERCE PHARMA
    26 Sep 2023
    Share Share
    Patient deaths taint Roche's landmark adjuvant liver cancer data
    Patient deaths taint Roche's landmark adjuvant liver cancer data

    16 Apr 2023

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/patient-deaths-taint-roches-industry-first-early-stage-liver-cancer-readout-tecentriq

    Angus Liu FIERCE PHARMA
    16 Apr 2023
    Share Share
    Roche's Tecentriq, Avastin combo cuts risk of liver cancer returning
    Roche's Tecentriq, Avastin combo cuts risk of liver cancer returning

    20 Jan 2023

    // BIOPHARMADIVE

    https://www.biopharmadive.com/news/roche-tecentriq-avastin-adjuvant-liver-cancer-phase-3/640755/

    BIOPHARMADIVE
    20 Jan 2023
    Share Share
    Another Avastin biosimilar joins the party as Roche's grip on the market loosens
    Another Avastin biosimilar joins the party as Roche's grip on the market loosens

    28 Sep 2022

    // Nicole DeFeudis ENDPTS

    https://endpts.com/another-avastin-biosimilar-joins-the-party-as-roches-grip-on-the-market-loosens/

    Nicole DeFeudis ENDPTS
    28 Sep 2022
    Share Share
    Genentech's Biologic AVASTIN(Bevacizumab) Receives Approval in the U.S.
    Genentech's Biologic AVASTIN(Bevacizumab) Receives Approval in the U.S.

    18 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125085

    FDA
    18 Sep 2022
    Share Share
    Celltrion’s Vegzelma receives EC approval for cancer treatments
    Celltrion’s Vegzelma receives EC approval for cancer treatments

    19 Aug 2022

    // PHARMACEUTICAL TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/celltrion-vegzelma-ec-approval/

    PHARMACEUTICAL TECHNOLOGY
    19 Aug 2022
    Share Share